SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000827871-17-000010
Filing Date
2017-11-08
Accepted
2017-11-08 17:05:27
Documents
71
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q egrx_q3x2017.htm 10-Q 1007900
2 EXHIBIT 10.2 exhibit102q32017.htm EX-10.2 472142
3 EXHIBIT 31.1 exhibit311q32017.htm EX-31.1 9700
4 EXHIBIT 31.2 exhibit312q32017.htm EX-31.2 9663
5 EXHIBIT 32.1 exhibit321q32017.htm EX-32.1 10019
12 redactedeaglesymbioli_image1.gif GRAPHIC 3321
13 redactedeaglesymbioli_image2.gif GRAPHIC 3539
  Complete submission text file 0000827871-17-000010.txt   5990454

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT egrx-20170930.xml EX-101.INS 1009562
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT egrx-20170930.xsd EX-101.SCH 40807
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT egrx-20170930_cal.xml EX-101.CAL 85095
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT egrx-20170930_def.xml EX-101.DEF 209974
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT egrx-20170930_lab.xml EX-101.LAB 548364
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT egrx-20170930_pre.xml EX-101.PRE 361817
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36306 | Film No.: 171187411
SIC: 2834 Pharmaceutical Preparations